Precision Medicine in BRAF-Mutated Non–Small Cell Lung Cancer

December 22nd 2016

Novel Treatment Approaches in Glioblastoma

December 21st 2016

EGFR-Targeted Therapy for NSCLC: Tolerability-Guided Dose Adjustment

December 17th 2016

Improving Prostate Cancer Outcomes: A Model for Shared Care

December 7th 2016

The Emerging Role of FLT3 Inhibitors in AML and ASM

December 1st 2016

Global Insights on Anti-Angiogenic Therapy for Metastatic Lung Cancer

November 11th 2016

Advanced Soft-Tissue Sarcoma: Integrating Monoclonal Antibody Therapy

November 8th 2016

Treatment Approaches in Non-Driver Lung Adenocarcinoma

October 31st 2016

Treating Beyond the First Line in HCC

October 31st 2016

Extended Adjuvant Endocrine Therapy: The Role of Genomic Profiling

October 24th 2016

Optimizing Treatment in Myeloproliferative Neoplasms

September 29th 2016

Georgetown University's Approach to Treating Advanced Colorectal Cancer

August 10th 2016

Relapsed Multiple Myeloma: Integrating Immunotherapy

July 27th 2016

Pancreatic Cancer: Optimizing Patient Outcomes

July 20th 2016

Implications of Tumor Sidedness in mCRC

July 14th 2016

Novel PI3K Inhibitors in B-Cell Malignancies

June 29th 2016

Global Expert Perspectives on Managing Excess Iron

June 28th 2016

Expert Perspectives on Hereditary Testing in Breast Cancer

May 31st 2016

Advancing Role of Immunotherapy in Multiple Myeloma

March 29th 2016

Treatment of Advanced Head & Neck Squamous Cell Carcinoma

March 21st 2016